Keith L Knutson Selected Research

Ascites

12/2017

IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keith L Knutson Research Topics

Disease

74	Neoplasms (Cancer) 05/2024 - 01/2002
30	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 06/2002
28	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2002
6	COVID-19 02/2024 - 01/2022
5	Rheumatoid Arthritis 01/2020 - 06/2010
4	Melanoma (Melanoma, Malignant) 04/2024 - 01/2002
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2024 - 01/2022
4	Infections 12/2018 - 10/2011
4	Carcinoma (Carcinomatosis) 04/2014 - 04/2006
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 08/2002
3	Disease Progression 07/2017 - 07/2006
3	Inflammation (Inflammations) 10/2013 - 06/2009
3	Prostatic Neoplasms (Prostate Cancer) 06/2010 - 08/2002
2	Experimental Melanoma 04/2024 - 01/2020
2	Rheumatic Diseases (Rheumatism) 03/2023 - 01/2023
2	Breast Diseases (Breast Disease) 01/2023 - 01/2018
2	Adenocarcinoma of Lung 11/2022 - 01/2019
2	Carcinogenesis 01/2018 - 02/2014
2	Ovarian Epithelial Carcinoma 06/2009 - 03/2008
2	Glioblastoma (Glioblastoma Multiforme) 07/2003 - 08/2002
1	Myositis (Idiopathic Inflammatory Myopathies) 03/2023
1	Sjogren's Syndrome (Sjogren Syndrome) 03/2023
1	Ankylosing Spondylitis 03/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2023
1	Psoriatic Arthritis 03/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Breakthrough Infections 04/2022
1	Cytopenia 04/2022
1	Hematologic Neoplasms (Hematological Malignancy) 04/2022
1	Triple Negative Breast Neoplasms 01/2020
1	Adenocarcinoma 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Eosinophilia 01/2019
1	Lymphoma (Lymphomas) 11/2018

Drug/Important Bio-Agent (IBA)

28	VaccinesIBA 11/2023 - 01/2002
19	AntigensIBA 10/2020 - 08/2002
17	Proteins (Proteins, Gene)FDA Link 05/2024 - 04/2002
16	Peptides (Polypeptides)IBA 12/2018 - 04/2002
13	Neoplasm Antigens (Tumor Antigens)IBA 01/2018 - 06/2002
12	EpitopesIBA 01/2020 - 07/2002
11	Biomarkers (Surrogate Marker)IBA 04/2024 - 07/2009
11	CytokinesIBA 01/2020 - 04/2006
9	Immune Checkpoint InhibitorsIBA 05/2024 - 11/2018
8	Monoclonal AntibodiesIBA 04/2024 - 02/2004
8	Messenger RNA (mRNA)IBA 02/2024 - 06/2014
7	Trastuzumab (Herceptin)FDA Link 10/2022 - 06/2010
6	Folate Receptor 1IBA 01/2020 - 09/2006
6	AntibodiesIBA 01/2020 - 01/2002
5	Interleukin-10 (Interleukin 10)IBA 12/2017 - 04/2008
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2011 - 05/2002
4	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 06/2010
4	mRNA VaccinesIBA 02/2024 - 04/2022
4	Interleukin-2 (IL2)IBA 01/2017 - 07/2006
4	HLA-DR Antigens (HLA-DR)IBA 02/2010 - 01/2006
4	EnzymesIBA 02/2010 - 05/2002
3	LigandsIBA 05/2024 - 06/2011
3	RNA (Ribonucleic Acid)IBA 12/2018 - 01/2012
3	Protein Subunit VaccinesIBA 01/2018 - 01/2003
3	Interleukin-8 (Interleukin 8)IBA 01/2017 - 10/2011
3	Cancer VaccinesIBA 12/2015 - 01/2006
3	Transcription Factors (Transcription Factor)IBA 07/2014 - 06/2009
3	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2013 - 05/2002
3	ImmunosorbentsIBA 02/2010 - 05/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2024 - 07/2011
2	COVID-19 VaccinesIBA 02/2024 - 01/2022
2	Hormones (Hormone)IBA 10/2022 - 08/2002
2	Estrogen ReceptorsIBA 11/2020 - 10/2006
2	Indicators and Reagents (Reagents)IBA 01/2017 - 04/2007
2	ChemokinesIBA 01/2017 - 01/2012
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2015 - 07/2011
2	invariant chain (Ii-Key)IBA 07/2011 - 01/2006
2	Folic Acid (Vitamin M)FDA LinkGeneric 07/2011 - 03/2008
2	NF-kappa B (NF-kB)IBA 05/2011 - 06/2009
2	flt3 ligand protein (flt3 ligand)IBA 01/2003 - 04/2002
1	Oncogene Proteins (Oncogene Protein)IBA 04/2024
1	Rituximab (Mabthera)FDA Link 03/2023
1	Protein Kinases (Protein Kinase)IBA 11/2022
1	B7-H1 AntigenIBA 11/2022
1	Auranofin (Ridaura)FDA Link 11/2022
1	ErbB Receptors (EGF Receptor)IBA 10/2022
1	Cyclin-Dependent Kinase 4IBA 04/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	pembrolizumabIBA 01/2020
1	margetuximabIBA 01/2020
1	durvalumabIBA 01/2020
1	Rheumatoid FactorIBA 01/2020
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2020
1	B 31IBA 01/2019
1	NivolumabIBA 01/2019
1	Chimeric Antigen ReceptorsIBA 12/2018
1	Tumor Biomarkers (Tumor Markers)IBA 12/2018
1	micaIBA 01/2018

Therapy/Procedure

37	Therapeutics 05/2024 - 07/2003
21	Immunotherapy 05/2024 - 01/2002
7	Drug Therapy (Chemotherapy) 04/2022 - 01/2004
1	Neoadjuvant Therapy 01/2024
1	Prophylactic Mastectomy 01/2023
1	Hyperthermic Intraperitoneal Chemotherapy 01/2021
1	Cytoreduction Surgical Procedures 01/2021